Subject(s)
Levodopa , Parkinson Disease , Ubiquitin-Protein Ligases , Humans , Parkinson Disease/drug therapy , Parkinson Disease/genetics , Levodopa/therapeutic use , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolism , Dystonia/genetics , Dystonia/drug therapy , Dystonia/chemically induced , Male , Female , Antiparkinson Agents/therapeutic use , Antiparkinson Agents/pharmacology , Adult , Gait/drug effects , Gait Disorders, Neurologic/genetics , Gait Disorders, Neurologic/etiology , Gait Disorders, Neurologic/drug therapyABSTRACT
Seizures are not common in cases with chronic liver disease. Overall seizures have been reported in 20-30% of cases in chronic liver disease associated with hepatic encephalopathy. We report two cases of chronic liver disease patients who presented with new-onset refractory focal status epilepticus (SE). Both patients had encephalitis and seizures which responded only when acyclovir was added to the treatment with antiepileptic medication. Herpes encephalitis should be considered as a possible diagnosis in new-onset focal seizures or focal SE in patients with chronic liver disease with or without hepatic encephalopathy, pending further investigations.
ABSTRACT
Optic disc edema may be caused by a number of conditions. A commonly ignored but important aspect is the presence of "infiltration" of disc; that may closely mimic disc edema. Disc edema, optic nerve dysfunction and a normal appearing disc in any combination may occur in infiltrative optic neuropathies. Identifying disc infiltration can aid in diagnosis of many sinister pathologies even in the absence of other specific clinical features. We describe two patients presenting with optic nerve dysfunction and infiltrated disc appearance, which on investigations were found to have underlying malignancies thereby underscoring the importance of detecting infiltrative optic neurpathies.